| 2024 |
Elliott, T. M., Neale, R. E., Foeglein, A., Webb, A., Karnon, J., Reid, I. R., . . . Gordon, L. G. (2024). Estimating population-level 25-hydroxyvitamin D concentrations in Australia and New Zealand using the sun exposure (SUNEX) microsimulation model. Journal of Photochemistry and Photobiology, 21, 100234.
DOI |
| 2024 |
Gray, J., Thynne, T. R., Eaton, V., Larcombe, R., Tantiongco, M., & Karnon, J. (2024). Using Expert Elicitation to Adjust Published Intervention Effects to Reflect the Local Context. MDM Policy and Practice, 9(1), 14 pages.
DOI |
| 2024 |
Wang, B., Andraweera, P., Danchin, M., Blyth, C. C., Vlaev, I., Ong, J., . . . Marshall, H. (2024). Nudging towards COVID-19 and influenza vaccination uptake in medically at-risk children: EPIC study protocol of randomised controlled trials in Australian paediatric outpatient clinics. BMJ Open, 14(2), 9 pages.
DOI |
| 2024 |
Putrik, P., Grobler, L., Lalor, A., Ramsay, H., Gorelik, A., Karnon, J., . . . O'Connor, D. (2024). Models for delivery and co-ordination of primary or secondary health care (or both) to older adults living in aged care facilities. Cochrane Database of Systematic Reviews, 2024(3), CD013880.
DOI Scopus1 Europe PMC1 |
| 2024 |
Karnon, J., & Pham, C. (2024). Adding Value to CHEERS: New Reporting Standards for Value of Information Analyses. Applied Health Economics and Health Policy, 22(2), 129-130.
DOI Scopus1 |
| 2023 |
Roseleur, J., Edney, L. C., Jung, J., & Karnon, J. (2023). Prevalence of unmet supportive care needs reported by individuals ever diagnosed with cancer in Australia: a systematic review to support service prioritisation. Supportive Care in Cancer, 31(12), 14 pages.
DOI |
| 2023 |
Karnon, J., Partington, A., Gray, J., Pincombe, A., & Schultz, T. (2023). Local Level Economic Evaluation: What is it? What is its value? Is it Sustainable?. Applied Health Economics and Health Policy, 9 pages.
DOI Scopus1 Europe PMC2 |
| 2023 |
Gray, J., Thynne, T. R., Eaton, V., Reade, B., Larcombe, R., Baldacchino, L., . . . Tantiongco, M. (2023). A framework for local-level economic evaluation to inform implementation decisions: health service interventions to prevent hospital-acquired hypoglycemia. International Journal of Technology Assessment in Health Care, 39(1), 11 pages.
DOI Scopus1 Europe PMC2 |
| 2023 |
Andraweera, P. H., Wang, B., Danchin, M., Blyth, C., Vlaev, I., Ong, J., . . . Marshall, H. S. (2023). Randomised controlled trials of behavioural nudges delivered through text messages to increase influenza and COVID-19 vaccines among pregnant women (the EPIC study): study protocol. Trials, 24(1), 454-1-454-8.
DOI Scopus1 Europe PMC1 |
| 2023 |
Pincombe, A., Afzali, H. H. A., Visvanathan, R., & Karnon, J. (2023). Development and validation of an individual-based state-transition model for the prediction of frailty and frailty-related events. PloS one, 18(8), 1-18.
DOI |
| 2023 |
Banham, D., Karnon, J., Brown, A., Roder, D., & Lynch, J. (2023). The fraction of life years lost after diagnosis (FLYLAD): a person-centred measure of cancer burden. Popul Health Metr, 21(1), 1-14.
DOI |
| 2023 |
Vallejo-Torres, L., Claxton, K., Edney, L. C., Karnon, J., Lomas, J., Ochalek, J., . . . Vanness, D. J. (2023). Challenges of calculating cost-effectiveness thresholds. The Lancet Global Health, 11(10), e1508.
DOI Scopus1 WoS1 |
| 2023 |
Pincombe, A., Mittinty, M. N., & Karnon, J. (2023). A scoping review of the statistical methods and risk-adjustment approaches used to compare cardiovascular disease services using Australian health system data. Healthcare Analytics, 4, 100250.
DOI |
| 2023 |
Edney, L. C., Haji Ali Afzali, H., Visvanathan, R., Toson, B., & Karnon, J. (2023). An exploration of healthcare use in older people waiting for and receiving Australian community-based aged care services. Geriatrics and Gerontology International, 23(12), 899-905.
DOI |
| 2023 |
Visvanathan, R., Lange, K., Selvam, J., Dollard, J., Boyle, E., Jones, K., . . . Hill, K. D. (2023). Findings from three methods to identify falls in hospitals: Results from the Ambient Intelligent Geriatric Management system fall prevention trial. Australasian Journal on Ageing, 43(1), 1-6.
DOI |
| 2023 |
Li, Q. C., Karnon, J., & Codde, J. (2023). Outcomes of completed quality activities in an Australian tertiary hospital, 2015–2019. International Journal for Quality in Health Care, 35(4), 7 pages.
DOI |
| 2023 |
Pham, C. T., Visvanathan, R., Strong, M., Wilson, E. C. F., Lange, K., Dollard, J., . . . Karnon, J. (2023). Cost-Effectiveness and Value of Information Analysis of an Ambient Intelligent Geriatric Management (AmbIGeM) System Compared to Usual Care to Prevent Falls in Older People in Hospitals.. Applied health economics and health policy, 21(2), 315-325.
DOI Scopus4 WoS3 Europe PMC2 |
| 2023 |
Koczwara, B., Knowles, R., Beatty, L., Shepherd, H. L., Shaw, J. M., Dhillon, H. M., . . . Butow, P. (2023). Implementing a web-based system of screening for symptoms and needs using patient-reported outcomes in people with cancer. Supportive Care in Cancer, 31(1), 7 pages.
DOI Scopus2 WoS1 Europe PMC1 |
| 2023 |
Leemans, S. J. J., Partington, A., Karnon, J., & Wynn, M. T. (2023). Process mining for healthcare decision analytics with micro-costing estimations. Artificial Intelligence in Medicine, 135, 102473-1-102473-12.
DOI Scopus5 WoS1 |
| 2023 |
Luker, S., Laver, K., Lane, R., Potter, E., Harrod, A. M., Bierer, P., . . . Crotty, M. (2023). ‘Put in a room and left’: a qualitative study exploring the lived experiences of COVID-19 isolation and quarantine among rehabilitation inpatients. Annals of Medicine, 55(1), 198-206.
DOI |
| 2023 |
De Zylva, R., Mortimer, E., Miller, E., Tsourtos, G., Lawn, S., Wilson, C., . . . Ward, P. (2023). Efficacy of mindfulness and goal setting interventions for increasing resilience and reducing smoking in lower socio-economic groups: randomised controlled trial protocol.. Addict Sci Clin Pract, 18(1), 7.
DOI |
| 2023 |
Roseleur, J., Gonzalez-Chica, D. A., Harvey, G., Stocks, N. P., & Karnon, J. (2023). The Cost of Uncontrolled Blood Pressure in Australian General Practice: A Modelling Study Using Electronic Health Records (MedicineInsight). PharmacoEconomics, 41(5), 573-587.
DOI |
| 2023 |
Owais, S. S., Arnolda, G., Lamprell, K., Liauw, W., Delaney, G. P., Olver, I., . . . Braithwaite, J. (2023). Age-related experiences of colorectal cancer diagnosis: a secondary analysis of the English National Cancer Patient Experience Survey. BMJ Open Gastroenterology, 10(1), e001066-1-e001066-12.
DOI |
| 2023 |
Edney, L. C., Roseleur, J., Bright, T., Watson, D. I., Arnolda, G., Braithwaite, J., . . . Karnon, J. (2023). DAta Linkage to Enhance Cancer Care (DaLECC): Protocol of a Large Australian Data Linkage Study. International Journal of Environmental Research and Public Health, 20(11), 5987.
DOI |
| 2023 |
Gray, J., Rachakonda, A., & Karnon, J. (2023). Pragmatic review of interventions to prevent catheter-associated urinary tract infections (CAUTIs) in adult inpatients. Journal of Hospital Infection, 136, 55-74.
DOI Scopus3 WoS1 |
| 2023 |
Roseleur, J., Gonzalez-Chica, D. A., Karnon, J., & Stocks, N. P. (2023). Predicted cardiovascular disease risk and prescribing of antihypertensive therapy among patients with hypertension in Australia using MedicineInsight.. Journal of human hypertension, 37(5), 370-378.
DOI Scopus6 WoS3 Europe PMC4 |
| 2023 |
Palmer, S., Borget, I., Friede, T., Husereau, D., Karnon, J., Kearns, B., . . . Borrill, J. (2023). A Guide to Selecting Flexible Survival Models to Inform Economic Evaluations of Cancer Immunotherapies. Value in Health, 26(2), 185-192.
DOI Scopus10 WoS7 Europe PMC6 |
| 2023 |
Pincombe, A., Schultz, T. J., Hofmann, D., & Karnon, J. (2023). Economic evaluation of a medical ambulatory care service using a single group interrupted time-series design. Journal of Evaluation in Clinical Practice, 29(2), 329-340.
DOI Scopus1 Europe PMC1 |
| 2022 |
Gray, J., Roseleur, J., Edney, L., Karnon, J., & Southern Adelaide Local Health Network’s (SALHN) Hypoglycaemia Clinical Working Group. (2022). Pragmatic review of interventions to prevent inpatient hypoglycaemia. Diabetic Medicine, 39(2), 16 pages.
DOI Scopus6 WoS2 Europe PMC2 |
| 2022 |
Grobler, L., O'Connor, D., Rischin, D., Putrik, P., Karnon, J., Rischin, K. J., . . . Buchbinder, R. (2022). Delivery of intravenous anti-cancer therapy at home versus in hospital or community settings for adults with cancer. Cochrane Database of Systematic Reviews, 2022(5).
DOI |
| 2022 |
Tong, M., Wondmagegn, B., Xiang, J., Hansen, A., Dear, K., Pisaniello, D., . . . Bi, P. (2022). Hospitalization Costs of Respiratory Diseases Attributable to Temperature in Australia and Projections for Future Costs in the 2030s and 2050s under Climate Change.. International journal of environmental research and public health, 19(15), 1-16.
DOI Scopus6 WoS2 Europe PMC2 |
| 2022 |
Karnon, J., Afzali, H. H. A., & Bonevski, B. (2022). An Economic Evaluation of Government-Funded COVID-19 Testing in Australia. Applied Health Economics and Health Policy, 20(5), 681-691.
DOI Scopus1 |
| 2022 |
Shafei, I., Karnon, J., & Crotty, M. (2022). Quality Improvement in Stroke Rehabilitation: A Scoping Review. Journal of Multidisciplinary Healthcare, 15, 2913-2931.
DOI Scopus6 WoS4 Europe PMC3 |
| 2022 |
Agarwal, A., Pain, T., Levesque, J. F., Girgis, A., Hoffman, A., Karnon, J., . . . Morton, R. L. (2022). Patient-reported outcome measures (PROMs) to guide clinical care: recommendations and challenges. Medical Journal of Australia, 216(1), 9-11.
DOI Scopus21 WoS11 Europe PMC10 |
| 2022 |
Williams, S., Nitschke, M., Wondmagegn, B. Y., Tong, M., Xiang, J., Hansen, A., . . . Bi, P. (2022). Evaluating cost benefits from a heat health warning system in Adelaide, South Australia. Australian and New Zealand Journal of Public Health, 46(2), 149-154.
DOI Scopus6 WoS3 |
| 2022 |
Karnon, J., Partington, A., & Afzali, H. (2022). Strategies for Avoiding Neglect of Opportunity Costs by Decision-Makers. Applied Health Economics and Health Policy, 20(1), 9-11.
DOI |
| 2022 |
Edney, L. C., Lomas, J., Karnon, J., Vallejo-Torres, L., Stadhouders, N., Siverskog, J., . . . Ochalek, J. (2022). Empirical Estimates of the Marginal Cost of Health Produced by a Healthcare System: Methodological Considerations from Country-Level Estimates. PharmacoEconomics, 40(1), 31-43.
DOI Scopus17 WoS14 Europe PMC9 |
| 2022 |
Duke, G. J., Moran, J. L., Bersten, A. D., Bihari, S., Roodenburg, O., Karnon, J., . . . Santamaria, J. D. (2022). Hospital-acquired complications: the relative importance of hospital- and patient-related factors. Medical Journal of Australia, 216(5), 242-247.
DOI Scopus9 WoS5 Europe PMC1 |
| 2022 |
Chuang, M. Y. A., Gnanamanickam, E. S., Karnon, J., Lambrakis, K., Horsfall, M., Blyth, A., . . . Chew, D. P. (2022). Cost effectiveness of a 1-hour high-sensitivity troponin-T protocol: an analysis of the RAPID-TnT trial. IJC Heart and Vasculature, 38, 1-8.
DOI Scopus4 WoS4 Europe PMC1 |
| 2022 |
Edney, L. C., Roseleur, J., Gray, J., Koczwara, B., & Karnon, J. (2022). Mapping a decade of interventions to address the supportive care needs of individuals living with or beyond cancer: a scoping review of reviews. Support Care Cancer, 30(5), 3793-3804.
DOI Scopus7 WoS6 Europe PMC2 |
| 2022 |
Nic Giolla Easpaig, B., Tran, Y., Winata, T., Lamprell, K., Fajardo Pulido, D., Arnolda, G., . . . Braithwaite, J. (2022). The complexities, coordination, culture and capacities that characterise the delivery of oncology services in the common areas of ambulatory settings.. BMC health services research, 22(1), 15 pages.
DOI |
| 2022 |
Marshall, H. S., Andraweera, P. H., Ward, J., Kaldor, J., Andrews, R., Macartney, K., . . . Whop, L. (2022). An observational study to assess the effectiveness of 4CMenB against meningococcal disease and carriage and gonorrhea in adolescents in the Northern Territory, Australia—study protocol. Vaccines, 10(2), 309-1-309-13.
DOI Scopus3 WoS2 Europe PMC1 |
| 2022 |
Chalwin, R., Salter, A., Karnon, J., Eaton, V., & Giles, L. (2022). Effect of a multi-faceted rapid response system re-design on repeat calling of the rapid response team.. PLoS One, 17(3), 1-13.
DOI Scopus1 WoS1 Europe PMC1 |
| 2022 |
Hillock, N. T., Merlin, T. L., Turnidge, J., & Karnon, J. (2022). Modelling the Future Clinical and Economic Burden of Antimicrobial Resistance: The Feasibility and Value of Models to Inform Policy. Applied Health Economics and Health Policy, 20(4), 479-486.
DOI Scopus9 WoS5 Europe PMC3 |
| 2022 |
Wondmagegn, B. Y., Xiang, J., Dear, K., Williams, S., Hansen, A., Pisaniello, D., . . . Bi, P. (2022). Understanding current and projected emergency department presentations and associated healthcare costs in a changing thermal climate in Adelaide, South Australia. Occupational and Environmental Medicine, 79(6), 421-426.
DOI Scopus3 Europe PMC1 |
| 2022 |
Visvanathan, R., Ranasinghe, D. C., Lange, K., Wilson, A., Dollard, J., Boyle, E., . . . Hill, K. (2022). Effectiveness of the wearable sensor based ambient intelligent geriatric management system (AmbIGeM) in preventing falls in older people in hospitals. Journals of Gerontology: Medical Sciences, 77(1), 155-163.
DOI Scopus10 WoS4 Europe PMC6 |
| 2021 |
Haji Ali Afzali, H., Street, J., Merlin, T., & Karnon, J. (2021). The representation of public values in health technology assessment to inform funding decisions: The case of Australia's national funding bodies. International Journal of Technology Assessment in Health Care, 37(1), 1-4.
DOI Scopus5 WoS3 Europe PMC2 |
| 2021 |
Vissapragada, R., Bulamu, N., Karnon, J., Yazbek, R., & Watson, D. I. (2021). Cost-effectiveness in surgery: concepts of cost-utility analysis explained. ANZ Journal of Surgery, 91(9), 1717-1723.
DOI Scopus12 WoS8 Europe PMC3 |
| 2021 |
Jadczak, A. D., Robson, L., Cooper, T., Bell, J. S., & Visvanathan, R. (2021). The Frailty In Residential Sector over Time (FIRST) study: methods and baseline cohort description. BMC Geriatrics, 21(1), 99-1-99-12.
DOI Scopus19 WoS15 Europe PMC9 |
| 2021 |
Wondmagegn, B. Y., Xiang, J., Dear, K., Williams, S., Hansen, A., Pisaniello, D., . . . Bi, P. (2021). Increasing impacts of temperature on hospital admissions, length of stay, and related healthcare costs in the context of climate change in Adelaide, South Australia. Science of the Total Environment, 773, 1-10.
DOI Scopus27 WoS20 Europe PMC5 |
| 2021 |
Searles, A., Piper, D., Jorm, C., Reeves, P., Gleeson, M., Karnon, J., . . . Gray, J. (2021). Embedding an economist in regional and rural health services to add value and reduce waste by improving local-level decision-making: protocol for the ‘embedded Economist’ program and evaluation. BMC Health Services Research, 21(1), 13 pages.
DOI Scopus4 WoS3 Europe PMC2 |
| 2021 |
Haji Ali Afzali, H., & Karnon, J. (2021). Expediting Patient Access to New Health Technologies: Role of Disease-Specific Reference Models. Value in Health, 24(6), 755-758.
DOI Scopus3 WoS1 Europe PMC2 |
| 2021 |
Putrik, P., Jessup, R., Buchbinder, R., Glasziou, P., Karnon, J., & O’Connor, D. A. (2021). Prioritising models of healthcare service delivery for a more sustainable health system: a Delphi study of Australian health policy, clinical practice and management, academic and consumer stakeholders. Australian Health Review, 45(4), 425-432.
DOI Scopus4 WoS4 Europe PMC2 |
| 2021 |
Putrik, P., Grobler, L., Lalor, A., Karnon, J., Parker, D., Morgan, M., . . . O'Connor, D. (2021). Models for delivery and co-ordination of primary or secondary health care (or both) to older adults living in aged care facilities. Cochrane Database of Systematic Reviews, 2021(3).
DOI |
| 2021 |
Harvey, G., Pham, C. T., Inacio, M. C., Laver, K., Lynch, E. A., Jorissen, R. N., . . . Crotty, M. (2021). An integrated knowledge translation approach to address avoidable rehospitalisations and unplanned admissions for older people in South Australia: implementation and evaluation program plan. Implementation science communications, 2(1), 1-7.
DOI Scopus4 Europe PMC2 |
| 2021 |
Wondmagegn, B. Y., Xiang, J., Dear, K., Williams, S., Hansen, A., Pisaniello, D., . . . Bi, P. (2021). Impact of heatwave intensity using excess heat factor on emergency department presentations and related healthcare costs in Adelaide, South Australia. Science of the Total Environment, 781, 146815-1-146815-9.
DOI Scopus19 WoS15 |
| 2021 |
Roseleur, J., Gonzalez-Chica, D. A., De Oliveira Bernardo, C., Geisler, B. P., Karnon, J., & Stocks, N. P. (2021). Blood pressure control in Australian general practice. Journal of Hypertension, 39(6), 1134-1142.
DOI Scopus10 WoS7 Europe PMC7 |
| 2021 |
Lambrakis, K., Papendick, C., French, J. K., Quinn, S., Blyth, A., Seshadri, A., . . . Chew, D. P. (2021). Late outcomes of the RAPID-TnT randomized controlled trial: 0/1-hour high-sensitivity troponin T protocol in suspected ACS. Circulation, 144(2), 113-125.
DOI Scopus29 WoS19 Europe PMC13 |
| 2021 |
Gesesew, H., Ward, P., Karnon, J., Woodman, R., & Mwanri, L. (2021). Peer-led HIV care and the UNAIDS 90-90-90 treatment targets in Tigrai, Ethiopia: a cluster randomised trial and economic evaluation of teach-test-link-trace model (TTLT) trial protocol. BMJ Open, 11(6), e043943-2-e043943-12.
DOI |
| 2021 |
Inacio, M. C., Jorissen, R. N., Khadka, J., Whitehead, C., Maddison, J., Bourke, A., . . . Crotty, M. (2021). Predictors of short-term hospitalization and emergency department presentations in aged care. Journal of the American Geriatrics Society, 69(11), 3142-3156.
DOI Scopus9 WoS6 Europe PMC4 |
| 2021 |
Tong, M. X., Wondmagegn, B. Y., Xiang, J., Williams, S., Hansen, A., Dear, K., . . . Bi, P. (2021). Emergency department visits and associated healthcare costs attributable to increasing temperature in the context of climate change in Perth, Western Australia, 2012-2019. Environmental Research Letters, 16(6), 1-12.
DOI Scopus6 WoS5 |
| 2021 |
Tong, X., Wondmagegn, B. Y., Xiang, J., Williams, S., Hansen, A., Dear, K., . . . Bi, P. (2021). Heat-attributable hospitalisation costs in Sydney: Current estimations and future projections in the context of climate change. Urban Climate, 40, 101028-1-101028-9.
DOI Scopus2 WoS1 |
| 2021 |
Bulamu, N. B., Vissapragada, R., Chen, G., Ratcliffe, J., Mudge, L. A., Smithers, B. M., . . . Wright, T. (2021). Responsiveness and convergent validity of QLU-C10D and EQ-5D-3L in assessing short-term quality of life following esophagectomy. Health and Quality of Life Outcomes, 19(1), 233-1-233-11.
DOI Scopus8 WoS6 Europe PMC6 |
| 2021 |
Inacio, M. C., Jorissen, R. N., Gaget, V., Tivey, D. R., Visvanathan, R., Karnon, J., & Maddern, G. J. (2021). National spending and uptake of mobile radiology services in aged care facilities: an opportunity to improve access remains. Internal Medicine Journal, 51(12), 2157-2159.
DOI Scopus3 Europe PMC3 |
| 2021 |
Partington, A., & Karnon, J. (2021). It's not the model, it's the way you use it: exploratory early health economics amid complexity; comment on "problems and promises of health technologies: the role of early health economic modelling". International Journal of Health Policy and Management, 10(1), 36-38.
DOI Scopus4 WoS2 Europe PMC2 |
| 2021 |
Schultz, T. J., Thomas, A., Georgiou, P., Juaton, M. S., Cusack, L., Simon, L., . . . Ravindran, J. (2021). Home infusions of natalizumab for people with multiple sclerosis: a pilot randomised crossover trial.. Annals of clinical and translational neurology, 8(8), 1610-1621.
DOI Scopus2 Europe PMC4 |
| 2021 |
Vissapragada, R., Bulamu, N. B., Brumfitt, C., Karnon, J., Yazbeck, R., & Watson, D. I. (2021). Improving cost-effectiveness of endoscopic surveillance for Barrett’s esophagus by reducing low-value care: a review of economic evaluations. Surgical Endoscopy, 35(11), 5905-5917.
DOI Scopus3 WoS1 Europe PMC1 |
| 2021 |
Li, Q. C., Karnon, J., Towler, S., & Codde, J. (2021). Characteristics of quality activities in a tertiary teaching hospital in Western Australia. International Journal for Quality in Health Care, 33(3), 8 pages.
DOI Scopus1 |
| 2021 |
Nic Giolla Easpaig, B., Tran, Y., Winata, T., Lamprell, K., Fajardo Pulido, D., Arnolda, G., . . . Braithwaite, J. (2021). Providing outpatient cancer care for CALD patients: a qualitative study. BMC Research Notes, 14(1), 304-1-304-8.
DOI Scopus2 WoS2 |
| 2021 |
Tong, X., Wondmagegn, B. Y., Williams, S., Hansen, A., Dear, K., Pisaniello, D., . . . Bi, P. (2021). Hospital healthcare costs attributable to heat and future estimations in the context of climate change in Perth, Western Australia. Advances in Climate Change Research, 12(5), 638-648.
DOI Scopus11 WoS7 |
| 2021 |
Gray, J., Partington, A., & Karnon, J. (2021). Access, Use, and Patient-Reported Experiences of Emergency Care during the COVID-19 Pandemic: Population-Based Survey. JMIR Human Factors, 8(3), 10 pages.
DOI Scopus3 WoS2 Europe PMC3 |
| 2021 |
van Welie, N., Pham, C. T., van Rijswijk, J., Dreyer, K., Verhoeve, H. R., Hoek, A., . . . Mol, B. W. J. (2021). The long-term costs and effects of tubal flushing with oil-based versus water-based contrast during hysterosalpingography. Reproductive BioMedicine Online, 42(1), 150-157.
DOI Scopus7 WoS6 Europe PMC3 |
| 2021 |
Hillock, N. T., Merlin, T. L., Karnon, J., Turnidge, J., & Eliott, J. (2021). Value assessment of antimicrobials and the implications for development, access, and funding of effective treatments: Australian stakeholder perspective.. International journal of technology assessment in health care, 37(1), 1-7.
DOI Scopus1 WoS1 Europe PMC1 |
| 2021 |
Van Welie, N., Pham, C. T., Van Rijswijk, J., Dreyer, K., Verhoeve, H. R., Hoek, A., . . . Mol, B. W. J. (2021). The Long-term Costs and Effects of Tubal Flushing With Oil-Based Versus Water-Based Contrast During Hysterosalpingography. Obstetrical and Gynecological Survey, 76(3), 156-157.
DOI |
| 2021 |
Gray, J., Sullivan, T., Latimer, N. R., Salter, A., Sorich, M. J., Ward, R. L., & Karnon, J. (2021). Extrapolation of Survival Curves Using Standard Parametric Models and Flexible Parametric Spline Models: Comparisons in Large Registry Cohorts with Advanced Cancer. Medical Decision Making : an international journal of the Society for Medical Decision Making, 41(2), 179-193.
DOI Scopus12 WoS9 Europe PMC6 |
| 2020 |
Edney, L. C., Gray, J., & Karnon, J. (2020). A scoping review of the economics of multidisciplinary teams in oncology care. Journal of Cancer Policy, 26, 100257-1-100257-11.
DOI Scopus7 WoS5 |
| 2020 |
Mol, B., & Karnon, J. (2020). Strict lockdown versus flexible social distance strategy for COVID-19 disease: a cost-effectiveness analysis.
DOI |
| 2020 |
Roseleur, J., Partington, A., & Karnon, J. (2020). Scoping review of Australian evaluations of healthcare delivery models: are we making the most of the evidence?. Australian Health Review, 44(4), 557-582.
DOI Scopus2 Europe PMC2 |
| 2020 |
Reyes Veliz, A., Gray, J., & Karnon, J. (2020). Economics of multidisciplinary teams in oncology: a scoping review protocol. JBI Evidence Synthesis, 18(6), 1285-1291.
DOI Scopus4 WoS4 Europe PMC3 |
| 2020 |
Hillock, N. T., Karnon, J., Turnidge, J., & Merlin, T. L. (2020). Estimating the utilisation of unregistered antimicrobials in Australia. Infection, Disease and Health, 25(2), 82-91.
DOI |
| 2020 |
Roseleur, J., Partington, A., & Karnon, J. (2020). Evaluations of healthcare delivery models in Australia: a scoping review protocol.. JBI database of systematic reviews and implementation reports, 18(1), 128-134.
DOI Scopus1 WoS1 |
| 2020 |
Pham, C., Lizarondo, L., Karnon, J., Aromataris, E., Munn, Z., Gibb, C., . . . Maddern, G. (2020). Strategies for implementing shared decision making in elective surgery by health care practitioners: A systematic review. Journal of Evaluation in Clinical Practice, 26(2), 582-601.
DOI Scopus13 WoS11 Europe PMC4 |
| 2020 |
Bae, S., Karnon, J., Crane, G., Bessen, T., Desai, J., Crowe, P., & Neuhaus, S. (2020). Cost-effectiveness analysis of imaging surveillance in stage II and III extremity soft tissue sarcoma: An Australian perspective. Cost Effectiveness and Resource Allocation, 18(1), 10 pages.
DOI Scopus8 WoS6 Europe PMC2 |
| 2020 |
Sullivan, T. R., Latimer, N. R., Gray, J., Sorich, M. J., Salter, A. B., & Karnon, J. (2020). Adjusting for treatment switching in oncology trials: a systematic review and rRecommendations for reporting. Value in Health, 23(3), 388-396.
DOI Scopus12 WoS9 Europe PMC9 |
| 2020 |
Karnon, J., & Pekarsky, B. (2020). Should Health Economic Evaluations Undertaken from a Societal Perspective Include Net Government Spending Multiplier Effects?. Applied Health Economics and Health Policy, 18(4), 467-475.
DOI Scopus1 WoS1 |
| 2020 |
Nandoskar, P., Coghlan, P., Moore, M. H., Ximenes, J., Moore, E. M., Karnon, J., & Watters, D. A. (2020). The Economic Value of the Delivery of Primary Cleft Surgery in Timor Leste 2000–2017. World Journal of Surgery, 44(6), 1699-1705.
DOI Scopus4 WoS3 Europe PMC1 |
| 2020 |
Karnon, J. (2020). A Simple Decision Analysis of a Mandatory Lockdown Response to the COVID-19 Pandemic. Applied Health Economics and Health Policy, 18(3), 329-331.
DOI Scopus45 WoS47 Europe PMC21 |
| 2020 |
Karnon, J. (2020). The Case for a Temporary COVID-19 Income Tax Levy Now, During the Crisis. Applied Health Economics and Health Policy, 18(3), 335-337.
DOI Scopus9 WoS7 Europe PMC3 |
| 2020 |
Hiscock, H., Perera, P., Tang, M. L. K., Danchin, M. H., Sung, V., & Karnon, J. (2020). Costs and uptake of a community model of paediatric food allergy care versus specialist hospital care: A before-and-after controlled trial. Journal of Paediatrics and Child Health, 56(8), 1225-1232.
DOI |
| 2020 |
Hillock, N. T., Merlin, T., Karnon, J., Turnidge, J., & Eliott, J. (2020). Feasibility of de-linking reimbursement of antimicrobials from sales: the Australian perspective as a qualitative case study. Journal of Antimicrobial Chemotherapy - Antimicrobial Resistance, 2(2), 1-7.
DOI Scopus3 WoS2 Europe PMC1 |
| 2020 |
Chalwin, R., Giles, L., Salter, A., Kapitola, K., & Karnon, J. (2020). Re-designing a rapid response system: effect on staff experiences and perceptions of rapid response team calls.. BMC Health Serv Res, 20(1), 480.
DOI Scopus9 WoS8 Europe PMC5 |
| 2020 |
Fradgley, E. A., Karnon, J., Roach, D., Harding, K., Wilkinson-Meyers, L., Chojenta, C., . . . Paul, C. L. (2020). Taking the pulse of the health services research community: A cross-sectional survey of research impact, barriers and support. Australian Health Review, 44(1), 160-167.
DOI Scopus7 WoS7 Europe PMC2 |
| 2019 |
Hillock, N. T., Paradiso, L., Turnidge, J., Karnon, J., & Merlin, T. (2019). Clinical indications treated with unregistered antimicrobials: The regulatory challenges of antimicrobial resistance and access to effective treatment for patients. Australian Health Review, 44(2), 263-269.
DOI Scopus2 WoS1 Europe PMC1 |
| 2019 |
Edney, L., Haji Ali Afzali, H., & Karnon, J. (2019). Are the benefits of new health services greater than their opportunity costs?. Australian Health Review, 43(5), 508-510.
DOI Scopus2 WoS3 |
| 2019 |
Banham, D., Karnon, J., Densley, K., & Lynch, J. W. (2019). How much emergency department use by vulnerable populations is potentially preventable?: A period prevalence study of linked public hospital data in South Australia. BMJ Open, 9(1), e022845.
DOI Scopus10 WoS8 Europe PMC5 |
| 2019 |
Banham, D., Karnon, J., & Lynch, J. (2019). Health related quality of life (HRQoL) among Aboriginal South Australians: A perspective using survey-based health utility estimates 11 Medical and Health Sciences 1117 Public Health and Health Services. Health and Quality of Life Outcomes, 17(1), 9 pages.
DOI Scopus5 WoS5 Europe PMC3 |
| 2019 |
Brazier, J., Ara, R., Azzabi, I., Busschbach, J., Chevrou-Séverac, H., Crawford, B., . . . Pickard, A. S. (2019). Identification, Review, and Use of Health State Utilities in Cost-Effectiveness Models: An ISPOR Good Practices for Outcomes Research Task Force Report. Value in Health, 22(3), 267-275.
DOI Scopus93 WoS80 Europe PMC62 |
| 2019 |
Lo, K., & Karnon, J. (2019). In-DEPtH framework: evidence-in formed, co-creation framework for the Design, Evaluation and Procurement of Health services. BMJ Open, 9(5), e026482-1-e026482-11.
DOI Scopus5 WoS2 Europe PMC1 |
| 2019 |
Roseleur, J., Harvey, G., Stocks, N., & Karnon, J. (2019). Behavioral economic insights to improve medication adherence in adults with chronic conditions: A scoping review protocol. JBI Database of Systematic Reviews and Implementation Reports, 17(9), 1915-1923.
DOI Scopus1 Europe PMC1 |
| 2019 |
Ishaque, S., Karnon, J., Chen, G., Nair, R., & Salter, A. B. (2019). A systematic review of randomised controlled trials evaluating the use of patient-reported outcome measures (PROMs). Quality of Life Research, 28(3), 567-592.
DOI Scopus80 WoS69 Europe PMC46 |
| 2019 |
Caro, J. J., Brazier, J. E., Karnon, J., Kolominsky-Rabas, P., McGuire, A. J., Nord, E., & Schlander, M. (2019). Determining Value in Health Technology Assessment: Stay the Course or Tack Away?. PharmacoEconomics, 37(3), 293-299.
DOI Scopus20 WoS16 Europe PMC8 |
| 2019 |
Chalwin, R., Giles, L., Salter, A., Eaton, V., Kapitola, K., & Karnon, J. (2019). Reasons for Repeat Rapid Response Team Calls, and Associations with In-Hospital Mortality. Joint Commission Journal on Quality and Patient Safety, 45(4), 268-275.
DOI Scopus5 WoS5 Europe PMC3 |
| 2019 |
Chew, D. P., Lambrakis, K., Blyth, A., Seshadri, A., Edmonds, M. J. R., Briffa, T., . . . Papendick, C. (2019). A randomized trial of a 1-hour troponin T protocol in suspected acute coronary syndromes: The Rapid Assessment of Possible Acute Coronary Syndrome in the Emergency Department with High-Sensitivity Troponin T Study (RAPID-TnT). Circulation, 140(19), 1543-1556.
DOI Scopus148 WoS118 Europe PMC60 |
| 2019 |
Afzali, H. H. A., Karnon, J., Theou, O., Beilby, J., Cesari, M., & Visvanathan, R. (2019). Structuring a conceptual model for cost effectiveness analysis of frailty interventions. PLoS ONE, 14(9), e0222049.
DOI Scopus10 WoS8 Europe PMC7 |
| 2019 |
Haji Ali Afzali, H., Bojke, L., & Karnon, J. (2019). Improving decision-making processes in health: is it time for (disease-specific) reference models?. Applied Health Economics and Health Policy, 18(1), 1-4.
DOI Scopus4 WoS4 Europe PMC2 |
| 2019 |
Nic Giolla Easpaig, B., Arnolda, G., Tran, Y., Bierbaum, M., Lamprell, K., Delaney, G. P., . . . Braithwaite, J. (2019). What is multidisciplinary cancer care like in practice? A protocol for a mixed-method study to characterise ambulatory oncology services in the Australian public sector. BMJ Open, 9(10), e031179-1-e031179-10.
DOI Scopus3 WoS3 Europe PMC3 |
| 2019 |
Visvanathan, R., Ranasinghe, D. C., Wilson, A., Lange, K., Dollard, J., Boyle, E., . . . Hill, K. (2019). Effectiveness of an Ambient Intelligent Geriatric Management system (AmbIGeM) to prevent falls in older people in hospitals: protocol for the AmbIGeM stepped wedge pragmatic trial. Injury Prevention, 25(3), 157-165.
DOI Scopus14 WoS9 Europe PMC5 |
| 2019 |
Gallagher, C., Hendriks, J. M. L., Giles, L., Karnon, J., Pham, C., Elliott, A. D., . . . Wong, C. X. (2019). Increasing trends in hospitalisations due to atrial fibrillation in Australia from 1993 to 2013. Heart, 105(17), 1358-1363.
DOI Scopus50 WoS38 Europe PMC17 |
| 2019 |
Pham, C. T., Gibb, C. L., Fitridge, R. A., Karnon, J., & Hoon, E. (2019). Supporting surgeons in patient-centred complex decision-making: a qualitative analysis of the impact of a perioperative physician clinic. BMJ Open, 9(12), e033277-1-e033277-9.
DOI Scopus2 |
| 2019 |
Roseleur, J., Harvey, G., Stocks, N., & Karnon, J. (2019). Behavioral Economic Insights to Improve Medication Adherence in Adults with Chronic Conditions: A Scoping Review. Patient, 12(6), 571-592.
DOI Scopus12 WoS8 Europe PMC5 |
| 2019 |
Schultz, T. J., Thomas, A., Georgiou, P., Cusack, L., Juaton, M., Simon, L., . . . Ravindran, J. (2019). Developing a Model of Care for Home Infusions of Natalizumab for People With Multiple Sclerosis.. Journal of infusion nursing : the official publication of the Infusion Nurses Society, 42(6), 289-296.
DOI Scopus9 WoS8 Europe PMC5 |
| 2018 |
Ishaque, S., Karnon, J., Chen, G., Nair, R., & Salter, A. (2018). A systematic review of randomized controlled trials evaluating the use of patient reported outcome measures (PROMs). QUALITY OF LIFE RESEARCH, 27, S41. |
| 2018 |
Laurence, C., Heywood, T., Bell, J., Atkinson, K., & Karnon, J. (2018). The never ending road: improving, adapting and refining a needs-based model to estimate future general practitioner requirements in two Australian states. Family Practice, 35(2), 193-198.
DOI Scopus5 WoS5 Europe PMC1 |
| 2018 |
Pham, C., Karnon, J., Norman, R., & Mol, B. (2018). Cost-effectiveness modelling of IVF in couples with unexplained infertility. Reproductive BioMedicine Online, 37(5), 555-563.
DOI Scopus9 WoS5 Europe PMC2 |
| 2018 |
Si, S., Moss, J., Karnon, J., & Stocks, N. (2018). Cost-effectiveness evaluation of the 45-49 year old health check versus usual care in Australian general practice: A modelling study. PLoS ONE, 13(11), 14 pages.
DOI Scopus5 WoS4 Europe PMC3 |
| 2018 |
Mumford, V., Baysari, M. T., Kalinin, D., Raban, M. Z., McCullagh, C., Karnon, J., & Westbrook, J. I. (2018). Measuring the financial and productivity burden of paediatric hospitalisation on the wider family network. Journal of Paediatrics and Child Health, 54(9), 987-996.
DOI Scopus31 WoS26 Europe PMC15 |
| 2018 |
Edney, L., Haji Ali Afzali, H., Cheng, T., & Karnon, J. (2018). Mortality reductions from marginal increases in public spending on health. Health Policy, 122(8), 892-899.
DOI Scopus16 WoS13 Europe PMC7 |
| 2018 |
Parker, S. M., Stocks, N., Nutbeam, D., Thomas, L., Denney-Wilson, E., Zwar, N., . . . Harris, M. F. (2018). Preventing chronic disease in patients with low health literacy using eHealth and teamwork in primary healthcare: protocol for a cluster randomised controlled trial. BMJ open, 8(6), e023239-1-e023239-9.
DOI Scopus16 WoS10 Europe PMC9 |
| 2018 |
Haji Ali Afzali, H., Bojke, L., & Karnon, J. (2018). Model structuring for economic evaluations of new health technologies. PharmacoEconomics, 36(11), 1309-1319.
DOI Scopus13 WoS12 Europe PMC7 |
| 2018 |
van Rijswijk, J., Pham, C., Dreyer, K., Verhoeve, H., Hoek, A., de Bruin, J., . . . Mol, B. (2018). Oil-based or water-based contrast for hysterosalpingography in infertile women: a cost-effective analysis of a randomized controlled trial. Fertility and Sterility, 110(4), 754-760.
DOI Scopus15 WoS12 Europe PMC7 |
| 2018 |
Dollard, J., Harvey, G., Dent, E., Trotta, L., Williams, N., Beilby, J., . . . Karnon, J. (2018). Older People Who are Frequent Users of Acute Care: A Symptom of Fragmented Care? A Case Series Report on Patients’ Pathways of Care. Journal of Frailty and Aging, 7(3), 193-195.
DOI Scopus12 WoS11 Europe PMC9 |
| 2018 |
Edney, L., Haji Ali Afzali, H., Cheng, T., & Karnon, J. (2018). Estimating the reference incremental cost-effectiveness ratio for the Australian health system. PharmacoEconomics, 36(2), 239-252.
DOI Scopus154 WoS130 Europe PMC79 |
| 2018 |
Thompson, M., Theou, O., Karnon, J., Adams, R., & Visvanathan, R. (2018). Frailty prevalence in Australia: findings from four pooled Australian cohort studies. Australasian Journal on Ageing, 37(2), 155-158.
DOI Scopus42 WoS36 Europe PMC23 |
| 2018 |
Karnon, J., Edney, L., & Afzali, H. (2018). The political economy of the assessment of value of new health technologies. Journal of Health Services Research and Policy, 23(2), 116-122.
DOI Scopus5 WoS4 Europe PMC1 |
| 2018 |
Karnon, J., Haghighi, B., Sajjad, B., Yem, S., Gamage, A., & Thorpe, A. (2018). COST-UTILITY ANALYSIS OF PRIVATE CONTRACTING TO REDUCE PUBLIC WAITING TIMES FOR JOINT REPLACEMENT SURGERY. International Journal of Technology Assessment in Health Care, 34(2), 147-155.
DOI Scopus3 WoS3 Europe PMC1 |
| 2018 |
Gray, J., Sullivan, T., Sorich, M., Salter, A., & Karnon, J. (2018). EXTRAPOLATION OF INDIVIDUAL SURVIVAL CURVES: WHAT CAN WE LEARN FROM REGISTRY DATA?. VALUE IN HEALTH, 21, S8.
DOI |
| 2017 |
Pham, C., Karnon, J., Middleton, P., Bloomfield, F., Groom, K., Crowther, C., & Mol, B. (2017). Randomised clinical trials in perinatal health care: a cost-effective investment. Medical Journal of Australia, 207(7), 289-293.
DOI Scopus7 WoS7 Europe PMC6 |
| 2017 |
Karnon, J., & Afzali, H. H. (2017). Predictive Validation and the Re-Analysis of Cost-Effectiveness: Do We Dare to Tread?. PharmacoEconomics, 35(11), 1111-1112.
DOI Scopus1 WoS1 Europe PMC1 |
| 2017 |
Dent, E., Hoon, E., Karnon, J., Kitson, A., Dollard, J., NEWBURY, J., . . . Beilby, J. (2017). Management of musculoskeletal conditions in rural South Australia: a randomised controlled trial. The Journal of Frailty & Aging, 6(4), 212-215.
DOI Scopus4 WoS3 Europe PMC1 |
| 2017 |
Banham, D., Chen, T., Karnon, J., Brown, A., & Lynch, J. (2017). Sociodemographic variations in the amount, duration and cost of potentially preventable hospitalisation for chronic conditions among Aboriginal and non-Aboriginal Australians: A period prevalence study of linked public hospital data. BMJ Open, 7(10), 1-13.
DOI Scopus16 WoS14 Europe PMC12 |
| 2017 |
Karnon, J. (2017). Heath State Utility Values for Cost-Effectiveness Models. PharmacoEconomics, 35(Suppl 1), S1-S3.
DOI Scopus4 WoS4 Europe PMC4 |
| 2017 |
Pham, C., Gibb, C., Fitridge, R., & Karnon, J. (2017). Effectiveness of preoperative medical consultations by internal medicine physicians: a systematic review. BMJ Open, 7(12), e018632-1-e018632-10.
DOI Scopus11 WoS9 Europe PMC7 |
| 2017 |
Papendick, C., Blyth, A., Seshadri, A., Edmonds, M., Briffa, T., Cullen, L., . . . Chew, D. (2017). A randomized trial of a 1-hour troponin T protocol in suspected acute coronary syndromes: design of the rapid assessment of possible ACS in the emergency department with high sensitivity troponin T (RAPID-TnT) study. American Heart Journal, 190, 25-33.
DOI Scopus19 WoS16 Europe PMC7 |
| 2017 |
Laurence, C., & Karnon, J. (2017). What will make a difference? Assessing the impact of policy and non-policy scenarios on estimations of the future GP workforce. Human Resources for Health, 15(1), 43-1-43-15.
DOI Scopus10 WoS10 Europe PMC4 |
| 2017 |
Ambagtsheer, R., Visvanathan, R., Cesari, M., Yu, S., Archibald, M., Schultz, T., . . . Beilby, J. (2017). Feasibility, acceptability and diagnostic test accuracy of frailty screening instruments in community-dwelling older people within the Australian general practice setting: a study protocol for a cross-sectional study. BMJ Open, 7(8), e016663-1-e016663-9.
DOI Scopus21 WoS16 Europe PMC12 |
| 2017 |
Gray, J., Hoon, E., Hajiali Afzali, H., Spooner, C., Harris, M. F., & Karnon, J. (2017). Is the Counterweight Program a feasible and acceptable option for structured weight management delivered by practice nurses in Australia? A mixed methods study. Australian Journal of Primary Health, 23(4), 348-363.
DOI Scopus4 WoS3 Europe PMC1 |
| 2017 |
Rothmore, P., Aylward, P., Gray, J., & Karnon, J. (2017). A long-term evaluation of the stage of change approach and compensable injury outcomes-a cluster-randomised trial. Ergonomics, 60(5), 628-635.
DOI Scopus5 WoS5 Europe PMC2 |
| 2017 |
Rothmore, P., Aylward, P., Oakman, J., Tappin, D., Gray, J., & Karnon, J. (2017). The stage of change approach for implementing ergonomics advice – Translating research into practice. Applied Ergonomics, 59(Pt A), 225-233.
DOI Scopus15 WoS11 Europe PMC4 |
| 2017 |
Hoon, E., Pham, C., Beilby, J., & Karnon, J. (2017). Unconnected and out-of-sight: identifying health care non-users with unmet needs. BMC Health Services Research, 17(1), 80.
DOI Scopus5 WoS5 Europe PMC2 |
| 2017 |
Partington, A., Chew, D., Ben-Tovim, D., Horsfall, M., Hakendorf, P., & Karnon, J. (2017). Screening for important unwarranted variation in clinical practice: a triple-test of processes of care, costs and patient outcomes. Australian Health Review, 41(1), 104-110.
DOI Scopus20 WoS13 Europe PMC10 |
| 2017 |
Kaambwa, B., Ratcliffe, J., Horsfall, M., Astley, C., Karnon, J., Coates, P., . . . Chew, D. (2017). Cost effectiveness of high-sensitivity troponin compared to conventional troponin among patients presenting with undifferentiated chest pain: a trial based analysis. International Journal of Cardiology, 238, 144-150.
DOI Scopus13 WoS10 Europe PMC8 |
| 2017 |
Karnon, J., Afzali, H., Putro, G., Thant, P., Dompok, A., Cox, I., . . . Cameron, I. (2017). A cost-effectiveness model for frail older persons: development and application to a physiotherapy-based intervention. Applied Health Economics and Health Policy, 15(5), 635-645.
DOI Scopus9 WoS8 Europe PMC4 |
| 2017 |
Karnon, J., Edney, L., & Sorich, M. (2017). Costs of paying higher prices for equivalent effects on the Pharmaceutical Benefits Scheme. Australian Health Review, 41(1), 1-6.
DOI Scopus9 WoS6 Europe PMC3 |
| 2016 |
Dent, E., Hoon, E., Kitson, A., Karnon, J., Newbury, J., Harvey, G., . . . Beilby, J. (2016). Translating a health service intervention into a rural setting: lessons learned Organization, structure and delivery of healthcare. BMC Health Services Research, 16(1), 62-1-62-9.
DOI Scopus12 WoS11 Europe PMC7 |
| 2016 |
Karnon, J. (2016). Model Validation: Has it’s Time Come?. PharmacoEconomics, 34(9), 829-831.
DOI Scopus4 WoS3 Europe PMC4 |
| 2016 |
Haji Ali Afzali, H., Karnon, J., & Sculpher, M. (2016). Should the Lambda (λ) Remain Silent?. PharmacoEconomics, 34(4), 323-329.
DOI Scopus8 WoS7 Europe PMC5 |
| 2016 |
Pham, C., Gibb, C., Mittinty, M., Fitridge, R., Marshall, V., & Karnon, J. (2016). A comparison of propensity score-based approaches to health service evaluation: a case study of a preoperative physician-led clinic for high-risk surgical patients. Journal of Evaluation in Clinical Practice, 22(5), 761-770.
DOI Scopus3 WoS1 Europe PMC2 |
| 2016 |
Karnon, J., & Orji, N. (2016). Option B+ for the prevention of mother-to-child transmission of HIV infection in developing countries: A review of published cost-effectiveness analyses. Health Policy and Planning, 31(8), 1133-1141.
DOI Scopus18 WoS17 Europe PMC15 |
| 2016 |
Laurence, C., & Karnon, J. (2016). Improving the planning of the GP workforce in Australia: a simulation model incorporating work transitions, health need and service usage. Human Resources for Health, 14(1), 13-1-13-14.
DOI Scopus18 WoS16 Europe PMC11 |
| 2016 |
Sutton, J., Koblar, S., Hamilton-Bruce, M. A., Jannes, J., Karnon, J., Sutton, D. A., . . . Kramer, S. (2016). Advanced management services for transient ischaemic attacks and minor stroke. Cochrane Database of Systematic Reviews, 2016(5), 1-14.
DOI |
| 2016 |
Karnon, J., Partington, A., Horsfall, M., & Chew, D. (2016). Variation in Clinical Practice: A Priority Setting Approach to the Staged Funding of Quality Improvement. Applied Health Economics and Health Policy, 14(1), 21-27.
DOI Scopus12 WoS9 Europe PMC8 |
| 2016 |
Dent, E., Hoon, E., Karnon, J., Newbury, J., Kitson, A., & Beilby, J. (2016). Frailty and health service use in rural South Australia. Archives of Gerontology and Geriatrics, 62, 53-58.
DOI Scopus23 WoS23 Europe PMC14 |
| 2016 |
Westbrook, J., Li, L., Raban, M., Baysari, M., Mumford, V., Prgomet, M., . . . Kennedy, P. (2016). Stepped-wedge cluster randomised controlled trial to assess the effectiveness of an electronic medication management system to reduce medication errors, adverse drug events and average length of stay at two paediatric hospitals: a study protocol. BMJ Open, 6(10), e011811-1-e011811-11.
DOI Scopus24 WoS15 Europe PMC12 |
| 2016 |
Karnon, J., Shafie, A., Orji, N., & Usman, S. (2016). What are we paying for? A cost-effectiveness analysis of patented denosumab and generic alendronate for postmenopausal osteoporotic women in Australia. Cost Effectiveness and Resource Allocation, 14(1), 11-1-11-10.
DOI Scopus14 WoS11 Europe PMC9 |
| 2016 |
Chehade, M. J., Gill, T. K., Kopansky-Giles, D., Schuwirth, L., Karnon, J., McLiesh, P., . . . Woolf, A. D. (2016). Building multidisciplinary health workforce capacity to support the implementation of integrated, people-centred Models of Care for musculoskeletal health. Best Practice and Research: Clinical Rheumatology, 30(3), 559-584.
DOI Scopus20 WoS17 Europe PMC14 |
| 2016 |
Lizarondo, L., Pham, C., Aromataris, E., Munn, Z., Gibb, C., & Karnon, J. (2016). Strategies for implementing shared decision making in elective surgery by healthcare practitioners: a systematic review protocol.. JBI Database System Rev Implement Rep, 14(12), 100-108.
DOI Europe PMC1 |
| 2015 |
Partington, A., Wynn, M., Suriadi, S., Ouyang, C., & Karnon, J. (2015). Process mining for clinical processes: a comparative analysis of four Australian hospitals. ACM Transactions on Management Information Systems, 5(4), 19-1-19-18.
DOI Scopus127 |
| 2015 |
Cornell, V., Beer, A., Faulkner, D., Karnon, J., & Beilby, J. (2015). Study highlights CDC improvements. Australian Ageing Agenda Community Care Review. |
| 2015 |
Karnon, J., & Partington, A. (2015). Cost-value analysis and the SAVE: a work in progress, but an option for localised decision making?. PharmacoEconomics, 33(12), 1281-1288.
DOI Scopus3 WoS3 Europe PMC1 |
| 2015 |
Rothmore, P., Aylward, P., & Karnon, J. (2015). The implementation of ergonomics advice and the stage of change approach. Applied Ergonomics: human factors in technology and society, 51, 370-376.
DOI Scopus35 WoS17 Europe PMC5 |
| 2015 |
Mnatzaganian, G., Karnon, J., Moss, J., Elshaug, A., Metz, M., Frank, O., & Hiller, J. (2015). Informing disinvestment with limited evidence: cobalamin deficiency in the fatigued. International Journal of Technology Assessment in Health Care, 31(3), 188-196.
DOI Europe PMC1 |
| 2015 |
Dodd, J. M., Ahmed, S., Karnon, J., Umberger, W., Deussen, A. R., Tran, T., . . . Robinson, J. S. (2015). The cost-effectiveness of providing antenatal lifestyle advice for women who are overweight or obese: the LIMIT randomised trial. BMC Obesity, 2(1), 14-1-14-9.
DOI Scopus16 Europe PMC13 |
| 2015 |
McCaffrey, N., Agar, M., Harlum, J., Karnon, J., Currow, D., & Eckermann, S. (2015). Better informing decision making with multiple outcomes cost-effectiveness analysis under uncertainty in cost-disutility space. PLoS One, 10(3), e0115544-1-e0115544-19.
DOI Scopus25 WoS21 Europe PMC20 |
| 2015 |
Bessen, T., Keefe, D. M. K., & Karnon, J. (2015). Does one size fit all? Cost utility analyses of alternative mammographic follow-up schedules, by risk of recurrence. International Journal of Technology Assessment in Health Care, 31(5), 281-288.
DOI Scopus8 WoS7 Europe PMC6 |
| 2015 |
Hordacre, B., Crotty, M., Pham, C., & Karnon, J. (2015). Evaluating the Performance of Amputee Services at Neighbouring Hospital: A Risk Adjusted Performance Analysis. The journal of aging research & clinical practice, Online. |
| 2015 |
Cheng, H., Pearson, A., Sung, S., Yu, W., Chen, C., & Karnon, J. (2015). Cost-Effectiveness of Noninvasive Central Blood Pressure Monitoring in the Diagnosis of Hypertension. American Journal of Hypertension, 28(5), 604-614.
DOI Scopus9 WoS12 Europe PMC8 |
| 2015 |
Haji Ali Afzali, H., & Karnon, J. (2015). Exploring structural uncertainty in model-based economic evaluations. PharmacoEconomics, 33(5), 435-443.
DOI Scopus21 WoS17 Europe PMC11 |
| 2014 |
Karnon, J., & Haji Ali Afzali, H. (2014). When to use Discrete Event Simulation (DES) for the economic evaluation of health technologies? A review and critique of the costs and benefits of DES. PharmacoEconomics, 32(6), 547-558.
DOI Scopus55 WoS44 Europe PMC26 |
| 2014 |
Afzali, H., Karnon, J., Beilby, J., Gray, J., Holton, C., & Banham, D. (2014). Practice nurse involvement in general practice clinical care: policy and funding issues need resolution. Australian Health Review, 38(3), 301-305.
DOI Scopus18 WoS17 Europe PMC10 |
| 2014 |
Bessen, T., & Karnon, J. (2014). A patient-level calibration framework for evaluating surveillance strategies: a case study of mammographic follow-up after early breast cancer. Value in Health, 17(6), 669-678.
DOI Scopus7 WoS7 Europe PMC6 |
| 2014 |
Bessen, T., Chen, G., Street, J., Eliott, J., Karnon, J., Keefe, D., & Ratcliffe, J. (2014). What sort of follow-up services would Australian breast cancer survivors prefer if we could no longer offer long-term specialist-based care? A discrete choice experiment. British Journal of Cancer, 110(4), 859-867.
DOI Scopus31 WoS28 Europe PMC18 |
| 2014 |
Gray, J., Haji Ali Afzali, H., Beilby, J., Holton, C., Banham, D., & Karnon, J. (2014). Practice nurse involvement in primary care depression management: an observational cost-effectiveness analysis. BMC Family Practice, 15(10), 10-1-10-11.
DOI Scopus4 WoS4 Europe PMC1 |
| 2014 |
Grzeskowiak, L., Dekker, G., Rivers, K., Roberts-Thomson, K., Roy, A., Davies, M., . . . Clifton, V. (2014). A randomized controlled trial to assess the clinical and cost effectiveness of a nurse-led Antenatal Asthma Management Service in South Australia (AAMS study). BMC Pregnancy and Childbirth, 14(1), 9.
DOI Scopus6 WoS8 Europe PMC8 |
| 2014 |
Pham, C., Gibb, C., Field, J., Gray, J., Fitridge, R., Marshall, V., & Karnon, J. (2014). Managing high-risk surgical patients: modifiable co-morbidities matter. ANZ Journal of Surgery, 84(12), 925-931.
DOI Scopus6 WoS5 Europe PMC2 |
| 2014 |
Paulden, M., McCabe, C., & Karnon, J. (2014). Achieving allocative efficiency in healthcare: nice in theory, not so NICE in practice?. PharmacoEconomics, 32(4), 315-318.
DOI Scopus8 WoS7 Europe PMC6 |
| 2014 |
Rothmore, P., Aylward, P., & Karnon, J. (2014). Ergonomics and musculoskeletal injury prevention interventions in healthcare: are they worth it?. Ergonomics Australia, 8(1), 1-5. |
| 2013 |
Crane, G., Kymes, S., Hiller, J., Casson, R., & Karnon, J. (2013). Development and calibration of a constrained resource health outcomes simulation model of hospital-based glaucoma services. Health Systems, 2(3), 181-197.
DOI Scopus3 WoS3 |
| 2013 |
Hajiali Afzali, H., Gray, J., Beilby, J., Holton, C., & Karnon, J. (2013). A model-based economic evaluation of improved primary care management of patients with type 2 diabetes in Australia. Applied Health Economics and Health Policy, 11(6), 661-670.
DOI Scopus6 WoS7 Europe PMC4 |
| 2013 |
Sorich, M., Horowitz, J., Sorich, W., Wiese, M., Pekarsky, B., & Karnon, J. (2013). Cost-effectiveness of using CYP2C19 genotype to guide selection of clopidogrel or ticagrelor in Australia. Pharmagenomics, 14(16), 2013-2021.
DOI Scopus31 WoS25 Europe PMC19 |
| 2013 |
Crane, G., Kymes, S., Hiller, J., Casson, R., Adam, M., & Karnon, J. (2013). Accounting for costs, qalys, and capacity constraints: using discrete-event simulation to evaluate alternative service delivery and organizational scenarios for hospital-based glaucoma services. Medical Decision Making, 33(8), 986-997.
DOI Scopus14 WoS10 Europe PMC4 |
| 2013 |
Yip, S., Crane, G., & Karnon, J. (2013). Systematic review of reducing population meat consumption to reduce greenhouse gas emissions and obtain health benefits: effectiveness and models assessments. International Journal of Public Health, 58(5), 683-693.
DOI Scopus35 WoS32 Europe PMC16 |
| 2013 |
Hajiali Afzali, H., Gray, J., Beilby, J., Holton, C., Banham, D., & Karnon, J. (2013). A risk-adjusted economic evaluation of alternative models of involvement of practice nurses in management of type 2 diabetes. Diabetic Medicine, 30(7), 855-863.
DOI Scopus9 WoS9 Europe PMC7 |
| 2013 |
Hajiali Afzali, H., Gray, J., & Karnon, J. (2013). Model performance evaluation (validation and calibration) in model-based studies of therapeutic interventions for cardiovascular diseases: A review and suggested reporting framework. Applied Health Economics and Health Policy, 11(2), 85-93.
DOI Scopus17 WoS17 Europe PMC14 |
| 2013 |
Karnon, J., Hajiali Afzali, H., Gray, J., Holton, C., Banham, D., & Beilby, J. (2013). A risk adjusted cost-effectiveness analysis of alternative models of nurse involvement in obesity management in primary care. Obesity, 21(3), 472-479.
DOI Scopus11 WoS10 Europe PMC8 |
| 2013 |
Hajiali Afzali, H., Karnon, J., & Merlin, T. (2013). Improving the accuracy and comparability of model-based economic evaluations of health technologies for reimbursement decisions: a methodological framework for the development of reference models. Medical Decision Making, 33(3), 325-332.
DOI Scopus27 WoS26 Europe PMC20 |
| 2013 |
Rothmore, P., Karnon, J., & Aylward, P. (2013). Implementation of interventions to prevent musculoskeletal injury at work - lost in translation?. Physical Therapy Reviews, 18(5), 344-349.
DOI Scopus7 WoS5 |
| 2013 |
McCaffrey, N., Agar, M., Harlum, J., Karnon, J., Currow, D., & Eckermann, S. (2013). Is home-based palliative care cost-effective? An economic evaluation of the palliative care extended packages at home (PEACH) pilot. BMJ Supportive and Palliative Care, 3(4), 431-435.
DOI Scopus31 WoS23 Europe PMC16 |
| 2012 |
Karnon, J., Stahl, J., Brennan, A., Caro, J., Mar, J., & Möller, J. (2012). Modeling using discrete event simulation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-4. Medical Decision Making, 32(5), 701-711.
DOI Scopus164 WoS136 Europe PMC82 |
| 2012 |
Briggs, A., Weinstein, M., Fenwick, E., Karnon, J., Sculpher, M., & Paltiel, A. (2012). Model parameter estimation and uncertainty analysis: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-6. Medical Decision Making, 32(5), 722-732.
DOI Scopus505 WoS451 Europe PMC359 |
| 2012 |
Gordon, J., Pham, C., Karnon, J., & Crotty, M. (2012). Monitoring progress in the management of hip fractures in South Australia, Australia. Archives of Osteoporosis, 7(1-2), 267-273.
DOI Scopus6 Europe PMC5 |
| 2012 |
Karnon, J., Caffrey, O., Pham, C., Grieve, R., Ben-Tovim, D., Hakendorf, P., & Crotty, M. (2012). Applying risk adjusted cost-effectiveness (RAC-E) analysis to hospitals: estimating the costs and consequences of variation in clinical practice. Health Economics, online(6), 1-12.
DOI Scopus14 WoS11 Europe PMC8 |
| 2012 |
Karnon, J., Tolley, K., Vieira, J., & Chandiwana, D. (2012). Lifetime cost-utility analyses of deferasirox in beta-thalassaemia patients with chronic iron overload: A UK perspective. Clinical Drug Investigation, 32(12), 805-815.
DOI Scopus13 WoS12 Europe PMC9 |
| 2012 |
Wade, V., Karnon, J., Eliott, J., & Hiller, J. (2012). Home videophones improve direct observation in Tuberculosis treatment: a mixed methods evaluation. PLoS One, 7(11), 1-13.
DOI Scopus58 WoS48 Europe PMC35 |
| 2012 |
Hoon, E., Newbury, J., Kitson, A., Whitford, D., Wilson, A., Karnon, J., . . . Beilby, J. (2012). The LINKIN Health Census process: design and implementation. BMC Health Services Research, 12(1), 1-10.
DOI Scopus5 WoS8 Europe PMC7 |
| 2012 |
Zeng, X., Karnon, J., Wang, S., Wu, B., Wan, X., & Peng, L. (2012). The cost of treating advanced non-small cell lung cancer: estimates from the Chinese experience. PLoS One, 7(10), 1-7.
DOI Scopus39 WoS33 Europe PMC28 |
| 2012 |
Karnon, J., Stahl, J., Brennan, A., Caro, J., Mar, J., & Moller, J. (2012). Modeling using discrete event simulation: a report of the ISPOR-SMDM modeling good research practices task force-4. Value in Health, 15(6), 821-827.
DOI Scopus163 WoS140 Europe PMC110 |
| 2012 |
Briggs, A., Weinstein, M., Fenwick, E., Karnon, J., Sculpher, M., & Paltiel, A. (2012). Model parameter estimation and uncertainty: A report of the ISPOR-SMDM modeling good research practices task force-6. Value in Health, 15(6), 835-842.
DOI Scopus469 WoS412 Europe PMC306 |
| 2012 |
Pham, C., Karnon, J., Caffrey, O., Ben-Tovim, D., Hakendorf, P., & Crotty, M. (2012). Evaluating the effects of variation in clinical practice: a risk adjusted cost-effectiveness (RAC-E) analysis of acute stroke services. BMC Health Services Research, 12(1), 2-20.
DOI Scopus7 WoS5 Europe PMC4 |
| 2012 |
Hajiali Afzali, H., Karnon, J., Gray, J., & Beilby, J. (2012). A model-based evaluation of collaborative care in management of patients with type 2 diabetes in Australia: an initial report. Australian Health Review, 36(3), 258-263.
DOI Scopus3 WoS4 Europe PMC3 |
| 2012 |
Hajiali Afzali, H., Karnon, J., & Gray, J. (2012). A critical review of model-based economic studies of depression: modelling techniques, model structure and data sources. Pharmacoeconomics, 30(6), 461-482.
DOI Scopus26 WoS20 Europe PMC14 |
| 2012 |
Hajiali Afzali, H., Karnon, J., Gray, J., & Beilby, J. (2012). Evaluation of collaborative models of care in the management of patients with depression: protocol and progress. Mental Health in Family Medicine, 9(2), 91-97.
Scopus1 |
| 2012 |
Delea, T., Tappenden, P., Sofrygin, O., Karnon, J., Browning, D., Amonkar, M., . . . Cameron, D. (2012). Cost-effectiveness of lapatinib plus capecitabine in women with HER2+ metastatic breast cancer who have received prior therapy with trastuzumab. The European Journal of Health Economics, 13(5), 589-603.
DOI Scopus20 WoS18 Europe PMC16 |
| 2012 |
Hajiali Afzali, H., Karnon, J., & Gray, J. (2012). A proposed model for economic evaluations of major depressive disorder. European Journal of Health Economics, 13(4), 501-510.
DOI Scopus15 WoS13 Europe PMC10 |
| 2012 |
Hoon-Leahy, C., Newbury, J., Kitson, A., Whitford, D., Wilson, A., Karnon, J., . . . Beilby, J. (2012). The LINKIN Health Census process: design and implementation.. BMC health services research, 12, 321.
DOI Scopus8 |
| 2011 |
Day, F., Karnon, J., & Rischin, D. (2011). Cost-effectiveness of universal hepatitis B virus screening in patients beginning chemotherapy for solid tumors.. J Clin Oncol, 29(15_suppl), 9054. |
| 2011 |
Karnon, J., Ben-Tovim, D., Pham, C., Caffrey, O., Hakendorf, P., Crotty, M., & Phillips, P. (2011). The efficient price: an opportunity for funding reform. Australian Health Review, 35(4), 501-506.
DOI Scopus4 WoS3 Europe PMC3 |
| 2011 |
Lux, M., Reichelt, C., Karnon, J., Tanzer, T., Radosavac, D., Fasching, P., . . . Thiel, F. (2011). Cost-benefit analysis of endocrine therapy in the adjuvant setting for postmenopausal patients with hormone receptor-positive breast cancer, based on survival data and future prices for generic drugs in the context of the German health care system. Breast Care, 6(5), 381-389.
DOI Scopus14 WoS14 Europe PMC11 |
| 2011 |
Banham, D., Lynch, J., & Karnon, J. (2011). An equity-effectiveness framework linking health programs and healthy life expectancy. Australian Journal of Primary Health, 17(4), 309-319.
DOI Scopus11 WoS10 Europe PMC9 |
| 2011 |
Piantadosi, C., Visvanathan, R., Naganathan, V., Hunter, P., Cameron, I., Lange, K., . . . Chapman, I. (2011). The effect of testosterone and a nutritional supplement on hospital admissions in under-nourished, older people. BMC Geriatrics, 11(66), 246-250.
DOI Scopus7 WoS7 Europe PMC5 |
| 2011 |
Day, F., Karnon, J., & Rischin, D. (2011). Cost-effectiveness of universal hepatitis B virus screening in patients beginning chemotherapy for solid tumors. Journal of Clinical Oncology, 29(24), 3270-3277.
DOI Scopus59 WoS51 Europe PMC40 |
| 2011 |
Vanni, T., Karnon, J., Madan, J., White, R., Edmunds, W., Foss, A., & Legood, R. (2011). Calibrating models in economic evaluation: A seven-step approach. Pharmacoeconomics, 29(1), 35-49.
DOI Scopus113 WoS102 Europe PMC81 |
| 2011 |
Karnon, J., & Vanni, T. (2011). Calibrating models in economic evaluation: A comparison of alternative measures of goodness of fit, parameter search strategies and convergence criteria. Pharmacoeconomics, 29(1), 51-62.
DOI Scopus46 WoS43 Europe PMC32 |
| 2011 |
Bryan, S., Dormandy, E., Roberts, T., Ades, A., Barton, P., Juarez-Garcia, A., . . . Marteau, T. (2011). Screening for sickle cell and thalassaemia in primary care: A cost-effectiveness study. British Journal of General Practice, 61(591), e620-e627.
DOI Scopus13 WoS12 Europe PMC7 |
| 2011 |
Laurence, C., Black, L., Cheah, C., & Karnon, J. (2011). Is different better? Models of teaching and their influence on the net financial outcome for general practice teaching posts. BMC Medical Education, 11(1), 45:1-45:8.
DOI Scopus8 WoS8 Europe PMC5 |
| 2011 |
Lu, C., Karnon, J., & Sorich, M. (2011). The importance of high-quality evidence of the long-term impact of nonfatal events used in randomized controlled trials: a case study of Prasugrel. Clinical Pharmacology & Therapeutics, 90(1), 27-29.
DOI Scopus6 WoS7 Europe PMC4 |
| 2011 |
Gray, J., Karnon, J., & Blackwell, L. (2011). Sugar consumption from beverages and the potential effects of a text-based information label. Australian and New Zealand Journal of Public Health, 35(1), 88-89.
DOI Scopus7 WoS6 Europe PMC3 |
| 2011 |
Haji Ali Afzali, H., & Karnon, J. (2011). Addressing the challenge for well informed and consistent reimbursement decisions: The case for reference models. PharmacoEconomics, 29(10), 823-825.
DOI Scopus16 WoS13 Europe PMC13 |
| 2011 |
Gordon, J., & Karnon, J. (2011). HEALTH TECHNOLOGY APPRAISAL OF NEW DRUGS: ARE WE GETTING IT RIGHT?. VALUE IN HEALTH, 14(7), A501.
DOI |
| 2011 |
Caffrey, O., Pham, C., Karnon, J., Ben-Tovim, D., Hakendorf, P., & Crotty, M. (2011). IDENTIFYING EFFICIENT ACUTE CLINICAL PATHWAYS FOR CHEST PAIN: USING RISK ADJUSTED COST-EFFECTIVENESS (RAC-E) TO COMPARE HOSPITALS USING LINKED, ROUTINELY COLLECTED DATA. VALUE IN HEALTH, 14(3), A52.
DOI |
| 2010 |
Karnon, J., & Kaura, S. (2010). Updated survival-based analysis using inverse probability of censoring weighted analysis (IPCW) to estimate the cost-effectiveness of letrozole and anastrozole versus tamoxifen as adjuvant therapy in postmenopausal women with early breast cancer. JOURNAL OF CLINICAL ONCOLOGY, 28(15), 1 page.
DOI WoS3 |
| 2010 |
Sofrygin, O., Delea, T. E., Tappenden, P., Karnon, J., Browning, D., Amonkar, M., . . . Cameron, D. A. (2010). Cost-effectiveness of lapatinib plus capecitabine (LAP plus C) versus capecitabine alone (C-only) or trastuzumab plus capecitabine (TZ plus C) in women with HER2-positive metastatic breast cancer (MBC) who have received prior therapy with trastuzumab (TZ) from the UK National Health Service (NHS) perspective. JOURNAL OF CLINICAL ONCOLOGY, 28(15), 1 page.
DOI |
| 2010 |
Laurence, C., Black, L., Karnon, J., & Briggs, N. (2010). To teach or not to teach? A cost-benefit analysis of teaching in private general practice. Medical Journal of Australia, 193(10), 608-613.
DOI Scopus27 WoS27 Europe PMC9 |
| 2010 |
Karnon, J. (2010). Medication errors - what is the best way to reduce their impact on patients' health?. Journal of Health Services Research & Policy, 15(Suppl 1), 60-63.
DOI Scopus1 WoS2 |
| 2010 |
Dormandy, E., Bryan, S., Gulliford, M., Roberts, T., Ades, A., Calnan, M., . . . Marteau, T. (2010). Antenatal screening for haemoglobinopathies in primary care: a cohort study and cluster randomised trial to inform a simulation model. The Screening for Haemoglobinopathies in First Trimester (SHIFT) trial. Health Technology Assessment, 14(20), 1-160.
DOI Scopus22 WoS16 Europe PMC72 |
| 2010 |
Czoski-Murray, C., Karnon, J., Jones, R., Smith, K., & Kinghorn, G. (2010). Cost-effectiveness of screening high-risk HIV-positive men who have sex with men (MSM) and HIV-positive women for anal cancer. Health Technology Assessment, 14(53), 1-101.
DOI Scopus49 WoS40 Europe PMC22 |
| 2010 |
Wade, V., Karnon, J., Elshaug, A., & Hiller, J. (2010). A systematic review of economic analyses of telehealth services using real time video communication. BMC Health Services Research, 10(233), 1-13.
DOI Scopus243 WoS206 Europe PMC135 |
| 2010 |
Dormandy, E., Gulliford, M., Bryan, S., Roberts, T., Calnan, M., Atkin, K., . . . Marteau, T. (2010). Effectiveness of earlier antenatal screening for sickle cell disease and thalassaemia in primary care: cluster randomised trial. British Medical Journal, 341(7779), C5132-1-C5132-10.
DOI Scopus27 WoS24 Europe PMC17 |
| 2010 |
Eckermann, S., Karnon, J., & Willan, A. (2010). The value of value of information: best informing research design and prioritization using current methods. Pharmacoeconomics, 28(9), 699-709.
DOI Scopus80 WoS74 Europe PMC56 |
| 2010 |
Karnon, J., Brennan, A., & Akehurst, R. (2010). Decision modeling to inform decision making: Seeing the wood for the trees. Medical Decision Making, 30(3), E20-E22.
DOI Scopus5 WoS5 Europe PMC3 |
| 2010 |
Karnon, J., Holmes, M., Williams, R., Bakhai, A., & Brennan, A. (2010). A cost-utility analysis of clopidogrel in patients with ST elevation acute coronary syndromes in the UK. International Journal of Cardiology, 140(3), 315-322.
DOI Scopus6 WoS6 Europe PMC6 |
| 2009 |
Hutchinson, A., Young, T., Cooper, K., McIntosh, J., Karnon, J., Scobie, S., & Thomson, R. (2009). Trends in healthcare incident reporting and relationship to safety and quality data in acute hospitals: results from the National Reporting and Learning System. Quality and Safety in Health Care, 18(1), 5-10.
DOI Scopus133 WoS115 Europe PMC87 |
| 2009 |
Liubao, P., Xiaomin, W., Chongqing, T., Karnon, J., Gannong, C., Jianhe, L., . . . Junhua, C. (2009). Cost-effectiveness analysis of adjuvant therapy for operable breast cancer from a Chinese perspective: Doxorubicin plus Cyclophosphamide versus Docetaxel plus Cyclophosphamide. Pharmacoeconomics, 27(10), 873-886.
DOI Scopus35 WoS33 Europe PMC23 |
| 2009 |
Karnon, J., Carlton, J., Czoski-Murray, C., & Smith, K. (2009). Informing disinvestment through cost-effectiveness modelling: is lack of data a surmountable barrier?. Applied Health Economics and Health Policy, 7(1), 1-9.
DOI Scopus15 WoS13 Europe PMC12 |
| 2009 |
Karnon, J., Campbell, F., & Czoski-Murray, C. (2009). Model-based cost-effectiveness analysis of interventions aimed at preventing medication error at hospital admission (medicines reconciliation). Journal of Evaluation in Clinical Practice, 15(2), 299-306.
DOI Scopus93 WoS78 Europe PMC66 |
| 2009 |
Karnon, J., Czoski-Murray, C., Smith, K., & Brand, C. (2009). A hybrid cohort individual sampling natural history model of age-related macular degeneration: Assessing the cost-effectiveness of screening using probabilistic calibration. Medical Decision Making, 29(3), 304-316.
DOI Scopus15 WoS14 Europe PMC12 |
| 2009 |
Elshaug, A., Moss, J., Littlejohns, P., Karnon, J., Merlin, T., & Hiller, J. (2009). Identifying existing health care services that do not provide value for money. Medical Journal of Australia, 190(5), 269-273.
DOI Scopus99 WoS95 Europe PMC57 |
| 2009 |
Delea, T., Sofrygin, O., Tappenden, P., Browning, D., Amonkar, M. M., Karnon, J., & Lykopoulos, K. (2009). COST-EFFECTIVENESS (CE) ANALYSIS OF ERBB2-TARGETED THERAPIES IN WOMEN WITH TRASTUZUMAB (TZ)-REFRACTORY ERBB2+METASTATIC BREAST CANCER (MBC) AND LIMITED EXPOSURE TO PRIOR CHEMOTHERAPY (CT). VALUE IN HEALTH, 12(3), A49.
DOI |
| 2009 |
Karnon, J., & Kaura, S. (2009). A survival-based cost-effectiveness analysis of 5 years of letrozole versus tamoxifen as adjuvant therapy in postmenopausal women with early breast cancer: 76-month update of BIG-1-98.. J Clin Oncol, 27(15_suppl), 6566. |
| 2009 |
Karnon, J., Jones, R., Czoski-Murray, C., & Smith, K. (2009). Erratum: Cost-utility analysis of screening high risk groups for anal cancer (Journal of Public Health (2008) 30 (293-304)). Journal of Public Health, 31(1), 194.
DOI Scopus1 WoS3 |
| 2008 |
Sofrygin, O., Delea, T., Tappenden, P., Karnon, J., Amonkar, M. M., & Walker, M. (2008). Validity of proportional hazards (PH) Weibull models for analyzing progression free survival (PFS) and overall survival (OS) in patients with trastuzumab (TZ)-refractory ERBB2+(HER2+) metastatic breast cancer (MBC) receiving lapatinib plus capecitabine (L+C) versus capecitabine only (C-only). VALUE IN HEALTH, 11(3), A57.
DOI |
| 2008 |
Dormandy, E., Kavalier, F., Logan, J., Harris, H., Ishmael, N., Marteau, T. M., . . . Wild, B. (2008). Maximising recruitment and retention of general practices in clinical trials: A case study. British Journal of General Practice, 58(556), 759-766.
DOI Scopus40 WoS34 Europe PMC29 |
| 2008 |
DeLea, T., Tappenden, P., Sofrygin, O., Karnon, J., Amonkar, M., Browning, D., . . . Walker, M. D. (2008). Cost-effectiveness (CE) of lapatinib plus capecitabine (L plus C) in women with HER2+metastatic breast cancer (MBC) who received prior therapy with trastuzumab (TZ) based on updated survival data from EGF100151. JOURNAL OF CLINICAL ONCOLOGY, 26(15), 1 page.
DOI |
| 2008 |
Karnon, J., Mody-Patel, N., & Kaura, S. (2008). Reflecting time dependency in hazard rates to analyse the cost-effectiveness of letrozole or anastrozole versus tamoxifen as adjuvant therapies for early breast cancer in hormone receptor-positive (HR+) postmenopausal women: The U.S. perspective. JOURNAL OF CLINICAL ONCOLOGY, 26(15), 1 page.
DOI |
| 2008 |
Karnon, J., Tolley, K., Oyee, J., Jewitt, K., Ossa, D., & Akehurst, R. (2008). Cost-utility analysis of deferasirox compared to standard therapy with desferrioxamine for patients requiring iron chelation therapy in the United Kingdom. Current Medical Research and Opinion, 24(6), 1609-1621.
DOI Scopus39 WoS33 Europe PMC30 |
| 2008 |
Karnon, J., Czoski-Murray, C., Smith, K., Brand, C., Chakravarthy, U., Davis, S., . . . Yang, Y. (2008). A preliminary model-based assessment of the cost-utility of a screening programme for early age-related macular degeneration.. Health technology assessment (Winchester, England), 12(27).
Scopus4 |
| 2008 |
Carlton, J., Karnon, J., Czoski-Murray, C., Smith, K. J., & Marr, J. (2008). The clinical effectiveness and cost-effectiveness of screening programmes for amblyopia and strabismus in children up to the age of 4-5 years: A systematic review and economic evaluation. Health Technology Assessment, 12(25), 1-+.
DOI Scopus132 WoS82 Europe PMC65 |
| 2008 |
Karnon, J., Czoski-Murray, C., Smith, K., Brand, C., Chakravarthy, U., Davis, S., . . . Yang, Y. (2008). A preliminary model-based assessment of the cost-utility of a screening programme for early age-related macular degeneration. Health Technology Assessment, 12(27), 1-146.
DOI Scopus22 WoS5 Europe PMC12 |
| 2008 |
Bansback, N., Ara, R., Karnon, J., & Anis, A. (2008). Economic evaluations in rheumatoid arthritis. Pharmacoeconomics, 26(5), 395-408.
DOI Scopus29 WoS25 Europe PMC21 |
| 2008 |
Karnon, J., Jones, R., Czoski-Murray, C., & Smith, K. (2008). Cost-utility analysis of screening high-risk groups for anal cancer. Journal of Public Health (Print Edition), 30(3), 293-304.
DOI Scopus38 WoS32 Europe PMC25 |
| 2008 |
Karnon, J., McIntosh, A., Dean, J., Bath, P., Hutchinson, A., Oakley, J., . . . Tappenden, P. (2008). Modelling the expected net benefits of interventions to reduce the burden of medication errors. Journal of Health Services Research & Policy, 13(2), 85-91.
DOI Scopus40 WoS43 Europe PMC20 |
| 2008 |
Karnon, J., Delea, T., & Barghout, V. (2008). Cost utility analysis of early adjuvant letrozole or anastrozole versus tamoxifen in postmenopausal women with early invasive breast cancer: the UK perspective. European Journal of Health Economics, 9(2), 171-183.
DOI Scopus29 WoS28 Europe PMC24 |
| 2008 |
Delea, T., El-Ouagari, K., Karnon, J., & Sofrygin, O. (2008). Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in postmenopausal women with hormone-receptor positive early breast cancer from a Canadian perspective. Breast Cancer Research and Treatment, 108(3), 375-387.
DOI Scopus33 WoS30 Europe PMC23 |
| 2007 |
Delea, T., Karnon, J., & Goss, P. (2007). Conclusions regarding relative cost-utility of alternative strategies for use of aromatase inhibitors in postmenopausal women with early breast cancer are premature. Annals of Oncology, 18(1), 197-198.
DOI Scopus1 WoS1 |
| 2007 |
Karnon, J., Goyder, E., Tappenden, P., McPhie, S., Towers, I., Brazier, J., & Madan, J. (2007). A review and critique of modelling in prioritising and designing screening programmes. Health Technology Assessment, 11(52), 1-3.
DOI Scopus47 WoS41 Europe PMC32 |
| 2007 |
Tappenden, P., Chilcott, J., Eggington, S., Patnick, J., Sakai, H., & Karnon, J. (2007). Option appraisal of population-based colorectal cancer screening programmes in England. Gut, 56(5), 677-684.
DOI Scopus121 WoS106 Europe PMC76 |
| 2007 |
Karnon, J., Brennan, A., & Akehurst, R. (2007). A critique and impact analysis of decision modeling assumptions. Medical Decision Making, 27(4), 491-499.
DOI Scopus20 WoS17 Europe PMC14 |
| 2007 |
Karnon, J., Kerr, G., Jack, W., Papo, N., & Cameron, D. (2007). Health care costs for the treatment of breast cancer recurrent events: Estimates from UK-based patient-level analysis. British Journal of Cancer, 97(4), 479-486.
DOI Scopus31 WoS29 Europe PMC22 |
| 2007 |
Delea, T., Karnon, J., Sofrygin, O., Thomas, S., Papo, N., & Barghout, V. (2007). Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in hormone receptor-positive postmenopausal women with early-stage breast cancer. Clinical Breast Cancer, 7(8), 608-618.
DOI Scopus23 WoS22 Europe PMC20 |
| 2007 |
Karnon, J. (2007). Cost-effectiveness of letrozole, anastrozole and exemestane for early adjuvant breast cancer. Expert Review of Pharmacoeconomics & Outcomes Research, 7(2), 143-154.
DOI Scopus5 Europe PMC2 |
| 2007 |
Karnon, J., McIntosh, A., Dean, J., Bath, P., Hutchinson, A., Oakley, J., . . . Tappenden, P. (2007). A prospective hazard and improvement analytic approach to predicting the effectiveness of medication error interventions. Safety Science, 45(4), 523-539.
DOI Scopus23 WoS17 |
| 2007 |
Ouagari, K., Karnon, J., Delea, T., Talbot, W., & Brandman, J. (2007). Cost-effectiveness of letrozole in the extended adjuvant treatment of women with early breast cancer. Breast Cancer Research and Treatment, 101(1), 37-49.
DOI Scopus22 WoS20 Europe PMC21 |
| 2007 |
Karnon, J., & Baladi, J. F. (2007). Modelling the cost-effectiveness of Deferasirox (Exjade) in the treatment of iron overloaded myelodysplastic syndrome patients. LEUKEMIA RESEARCH, 31, S134.
DOI WoS1 |
| 2007 |
Karnon, J., Kaura, S., & di Trapani, F. (2007). Comparison of the cost per distant disease free year gained of upfront letrozole or anastrozole, or switched exemestane versus tamoxifen for early breast cancer in hormone receptor positive (HR+) postmenopausal women: the UK perspective. BREAST, 16, S64. |
| 2006 |
Delea, T. E., Karnon, J., Barghout, V., Thomas, S. K., & Papo, N. L. (2006). Cost-effectiveness of letrozole and anastrozole as adjuvant therapy for hormone receptor positive early breast cancer in postmenopausal women.. J Clin Oncol, 24(18_suppl), 10577. |
| 2006 |
Karnon, J. (2006). Aromatase inhibitors in breast cancer: A review of cost considerations and cost effectiveness. Pharmacoeconomics, 24(3), 215-232.
DOI Scopus27 WoS24 Europe PMC18 |
| 2006 |
Karnon, J., Delea, T., Johnston, S., Smith, R., Brandman, J., Sung, J., & Goss, P. (2006). Cost effectiveness of extended adjuvant letrozole in postmenopausal women after adjuvant tamoxifen therapy: The UK perspective. Pharmacoeconomics, 24(3), 237-250.
DOI Scopus34 WoS32 Europe PMC27 |
| 2006 |
Karnon, J., Bakhai, A., Brennan, A., Pandor, A., Flather, M., Warren, E., . . . Akehurst, R. (2006). A cost-utility analysis of clopidogrel in patients with non-ST-segment-elevation acute coronary syndromes in the UK. International Journal of Cardiology, 109(3), 307-316.
DOI Scopus23 WoS20 Europe PMC18 |
| 2006 |
Delea, T., Karnon, J., Smith, R., Johnston, S., Brandman, J., Sung, J., & Goss, P. (2006). Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer. American Journal of Managed Care, 12(7), 374-386.
Scopus39 WoS35 Europe PMC30 |
| 2005 |
Karnon, J., Brennan, A., Pandor, A., Fowkes, G., Lee, A., Gray, D., . . . Akehurst, R. (2005). Modelling the long term cost effectiveness of clopidogrel for the secondary prevention of occlusive vascular events in the UK. Current Medical Research and Opinion, 21(1), 101-112.
DOI Scopus38 WoS28 Europe PMC25 |
| 2005 |
Karnon, J., Tsuchiya, A., & Dolan, P. (2005). Developing a relativities approach to valuing the prevention of non-fatal work-related accidents and ill health. Health Economics, 14(11), 1103-1115.
DOI Scopus3 WoS2 |
| 2005 |
Pickvance, S., Karnon, J., & Peters, J. (2005). Impact of a European chemicals strategy on occupational respiratory and skin diseases in 2005. EUROPEAN JOURNAL OF PUBLIC HEALTH, 15, 105-106. |
| 2005 |
Karnon, J., Johnston, S. R. D., Delea, T., Barghout, V., Thomas, S., & Papo, N. L. (2005). Letrozole is cost-effective versus tamoxifen as adjuvant therapy in postmenopausal women with early breast cancer: BIG-1-98. EJC SUPPLEMENTS, 3(2), 96.
WoS4 |
| 2005 |
Karnon, J., Delea, T. E., Papo, N. L., Barghout, V., Thomas, S. K., & Johnston, S. R. (2005). Cost-effectiveness analysis of letrozole versus tamoxifen as initial adjuvant therapy in hormone-receptor positive postmenopausal women with early breast cancer in the UK. VALUE IN HEALTH, 8(6), A43.
DOI |
| 2004 |
Karnon, J., Johnston, S. R., Delea, T. E., Smith, R. E., Brandman, J., Sung, J. C., & Goss, P. E. (2004). Cost-effectiveness of extended adjuvant letrozole after five years of tamoxifen in postmenopausal early breast cancer.. J Clin Oncol, 22(14_suppl), 6044. |
| 2004 |
Karnon, J., Johnston, S. R., Delea, T., Smith, R., Brandman, J., & Sung, J. (2004). Cost-effectiveness of extended adjuvant letrozole after five years of tamoxifen in postmenopausal early breast cancer. ANNALS OF ONCOLOGY, 15, 63.
WoS1 |
| 2004 |
Karnon, J., Peters, J., Chilcott, J., McGoogan, E., & Brewer, N. (2004). Liquid-based cytology in cervical screening: an updated rapid and systematic review and economic analysis.. Health Technology Assessment, 8(20), 1-78.
DOI Scopus123 WoS100 Europe PMC51 |
| 2004 |
Karnon, J. (2004). Cost-effectiveness of letrozole in the treatment of advanced breast cancer. Expert Review of Pharmacoeconomics & Outcomes Research, 4(4), 383-391.
DOI Scopus1 |
| 2004 |
Bansback, N., Ward, S., & Karnon, J. (2004). “Economic evaluation of gemcitabine in the treatment of pancreatic cancer in the UK”: How important is quality of life?. European Journal of Health Economics, 5(2), 188-189.
DOI Scopus3 Europe PMC2 |
| 2003 |
Chilcott, J., Brennan, A., Booth, A., Karnon, J., & Tappenden, P. (2003). The role of modelling in prioritising and planning clinical trials. Health Technology Assessment, 7(23), 1-125.
DOI Scopus73 Europe PMC14 |
| 2003 |
Karnon, J., Johnston, S., Jones, T., & Glendenning, A. (2003). A trial-based cost-effectiveness analysis of letrozole followed by tamoxifen versus tamoxifen followed by letrozole for postmenopausal advanced breast cancer. Annals of Oncology, 14(11), 1629-1633.
DOI Scopus24 WoS20 Europe PMC18 |
| 2003 |
Dezateux, C., Brown, J., Arthur, R., Karnon, J., & Parnaby, A. (2003). Performance treatment pathways and effects of alternative policy options for screening for developmental dysplasia of the hip in the United Kingdom. Archives of Disease in Childhood, 88(9), 753-759.
DOI Scopus46 WoS37 Europe PMC24 |
| 2003 |
Brown, J., Dezateux, C., Karnon, J., Parnaby, A., & Arthur, R. (2003). Efficiency of alternative policy options for screening for developmental dysplasia of the hip in the United Kingdom. Archives of Disease in Childhood, 88(9), 760-766.
DOI Scopus29 WoS16 Europe PMC11 |
| 2003 |
Karnon, J. (2003). Alternative decision modelling techniques for the evaluation of health care technologies: Markov processes versus discrete event simulation. Health Economics, 12(10), 837-848.
DOI Scopus108 WoS95 Europe PMC63 |
| 2003 |
Karnon, J., & Jones, T. (2003). A stochastic economic evaluation of letrozole versus tamoxifen as a first-line hormonal therapy: for advanced breast cancer in postmenopausal patients. Pharmacoeconomics, 21(7), 513-525.
DOI Scopus26 WoS18 Europe PMC15 |
| 2003 |
Karnon, J., Brennan, A., & Chilcott, J. (2003). Commentary on Coyle et al., "The assessment of the economic return from controlled clinical trials". European Journal of Health Economics, 4(3), 239-240.
DOI Scopus1 Europe PMC1 |
| 2002 |
Karnon, J., & Brown, J. (2002). Tamoxifen plus chemotherapy versus tamoxifen alone as adjuvant therapies for node-positive postmenopausal women with early breast cancer: A stochastic economic evaluation. Pharmacoeconomics, 20(2), 119-137.
DOI Scopus24 WoS20 Europe PMC19 |
| 2002 |
Karnon, J. (2002). Planning the efficient allocation of research funds: An adapted application of a non-parametric Bayesian value of information analysis. Health Policy, 61(3), 329-347.
DOI Scopus24 WoS18 Europe PMC13 |
| 2001 |
Karnon, J., & Qizilbash, N. (2001). Economic evaluation alongside n-of-1 trials: getting closer to the margin. Health Economics, 10(1), 79-82.
DOI WoS12 Europe PMC11 |
| 2001 |
Campbell, H., Karnon, J., & Dowie, R. (2001). Cost analysis of a hospital-at-home initiative using discrete event simulation. Journal of Health Services Research & Policy, 6(1), 14-22.
DOI Scopus20 Europe PMC8 |
| 2001 |
Sharples, L., Taylor, G., Karnon, J., Caine, N., Buxton, M., McNeil, K., & Wallwork, J. (2001). A model for analyzing the cost of the main clinical events after lung transplantation. Journal of Heart and Lung Transplantation, 20(4), 474-482.
DOI Scopus17 WoS14 Europe PMC9 |
| 2001 |
Karnon, J., & Qizilbash, N. (2001). The world-wide growth in obesity: An economic research agenda. Health Economics, 10(1), 1-7.
DOI Scopus134 Europe PMC56 |
| 2000 |
Karnon, J., Zeuner, D., Ades, A. E., Efimba, W., Brown, J., & Yardumian, A. (2000). The effects of neonatal screening for sickle cell disorders on lifetime treatment costs and early deaths avoided: A modelling approach. Journal of Public Health Medicine, 22(4), 500-511.
DOI Scopus17 WoS12 Europe PMC6 |
| 1999 |
Brown, J., Karnon, J., Eldabi, T., & Paul, R. J. (1999). Using modelling in a phased approach to the economic evaluation of adjuvant therapy for early breast cancer. Critical Reviews in Oncology/Hematology, 32(2), 95-103.
DOI Scopus3 WoS4 Europe PMC1 |
| 1999 |
Karnon, J., Zeuner, D., Brown, J., Ades, A. E., Wonke, B., & Modell, B. (1999). Lifetime treatment costs of β-thalassaemia major. Clinical and Laboratory Haematology, 21(6), 377-385.
DOI Scopus69 WoS54 Europe PMC45 |
| 1999 |
Zeuner, D., Ades, A. E., Karnon, J., Brown, J., Dezateux, C., & Anionwu, E. N. (1999). Antenatal and neonatal haemoglobinopathy screening in the UK: Review and economic analysis. Health Technology Assessment, 3(11), i-186.
DOI Scopus80 Europe PMC18 |
| 1998 |
Karnon, J., & Brown, J. (1998). Selecting a decision model for economic evaluation: A case study and review. Health Care Management Science, 1(2), 133-140.
DOI Scopus63 Europe PMC40 |
